AstraZeneca PLC ADR
Price & Volume
Stats
See more52W Range | $59.19-$87.67 |
Market Cap | $207.5B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $51.2B |
Revenue Growth (YoY) | 18% |
Gross Profit (12 Mos) | $42.2B |
Diluted EPS | $2.08 |
News
See moreYahoo Finance • 8 hours ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AZN
Yahoo Finance • 8 hours ago
ASTRAZENECA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AstraZeneca PLC and Encourages Investors to Contact the Firm
Yahoo Finance • 16 hours ago
The Gross Law Firm Notifies Shareholders of AstraZeneca PLC (AZN) of a Class Action Lawsuit and an Upcoming Deadline
Yahoo Finance • 2 days ago
AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman
About
CEO | Mr. Pascal Soriot D.V.M., M.B.A. |
CFO | Dr. Aradhana Sarin M.D. |
Address | 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Full-Time Employees | 89,900 |
